0001567619-19-010448.txt : 20190510
0001567619-19-010448.hdr.sgml : 20190510
20190510171601
ACCESSION NUMBER: 0001567619-19-010448
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190508
FILED AS OF DATE: 20190510
DATE AS OF CHANGE: 20190510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kramer Robert
CENTRAL INDEX KEY: 0001380956
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 19815997
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2019-05-08
0
0001367644
Emergent BioSolutions Inc.
EBS
0001380956
Kramer Robert
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
President and CEO
Common Stock
2019-05-08
4
F
0
95
47.49
D
111394
D
Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated.
/s/ S. Scott Lieberman, Attorney-in-fact
2019-05-10